LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival

被引:22
作者
Liang, Meng [1 ]
Wang, Linlin [2 ]
Cao, Chuanhua [3 ]
Song, Shimao [1 ]
Wu, Feng [1 ]
机构
[1] Hubei Univ Med, Taihe Hosp, Dept Oncol, 32 South Renmin Rd, Shiyan 442000, Hubei, Peoples R China
[2] Hubei Univ Med, Renmin Hosp, Dept Radiol, Shiyan 442000, Hubei, Peoples R China
[3] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Affiliated Hosp, Dept Oncol, Xiangyang 441021, Hubei, Peoples R China
关键词
SNHG10; miR-21; NSCLC; Methylation; PROLIFERATION; BIOMARKER; THERAPY;
D O I
10.1186/s12890-020-01281-w
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background LncRNA SNHG10 has been reported to be an oncogenic lncRNA in liver cancer. However, its roles in non-small cell lung cancer (NSCLC) remains unknown. Methods Tumor and paired non-tumor tissues were harvested from 62 NSCLC patients. RT-qPCR was used to detect the expression of SNHG10 and miR-21 in tissues. Overexpression experiments were used to evaluate the interaction between SNHG10 and miR-21 in NSCLC cells. CCK-8 assay was used to detect the cell proliferation. Results We observed the expression of SNHG10 was down-regulated in non-small cell lung cancer (NSCLC) compared with that in non-tumor tissues. Moreover, we found that high expression levels of SNHG10 predicted favorable survival of NSCLC patients, and the expression of miR-21 were increased in NSCLC and inversely correlated with SNHG10 expression. In NSCLC cells, overexpression of SNHG10 resulted in increased miR-21 gene methylation and decreased miR-21 expression. Moreover, overexpression of SNHG10 attenuated the enhancing effect of miR-21 overexpression on cell proliferation. Conclusions SNHG10 may involve in NSCLC cell proliferation by regulating the miR-21 gene methylation.
引用
收藏
页数:6
相关论文
共 50 条
[41]   TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer [J].
Lin, Anqi ;
Zhang, Hongman ;
Meng, Hui ;
Deng, Ze ;
Gu, Tianqi ;
Luo, Peng ;
Zhang, Jian .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[42]   Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer [J].
Luo, Jinmei ;
Song, Junli ;
Feng, Pinning ;
Wang, Yanhong ;
Long, Weiqing ;
Liu, Min ;
Li, Laisheng .
TUMOR BIOLOGY, 2016, 37 (08) :10715-10721
[43]   ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival [J].
Ni, Shuang-Shuang ;
Zhang, Ji ;
Zhao, Wei-Li ;
Dong, Xiao-Chun ;
Wang, Jin-Lin .
TUMOR BIOLOGY, 2013, 34 (03) :1813-1818
[44]   Controlling nutritional status predicts postoperative survival and acute exacerbation in resected non-small cell lung cancer with interstitial lung disease [J].
Matsubara, Taichi ;
Shimokawa, Mototsugu ;
Wakasu, Sho ;
Haro, Akira ;
Yamaguchi, Masafumi ;
Hamatake, Motoharu .
LUNG CANCER, 2025, 205
[45]   SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival [J].
Chen, Jingxia ;
Chen, Hongfen ;
Yang, Hanbing ;
Dai, Huizhen .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 100 :233-239
[46]   SMOX expression predicts the prognosis of non-small cell lung cancer [J].
Huang, Zhanghao ;
Wang, Shuo ;
Zhang, Hai-Jian ;
Zhou, You Lang ;
Shi, Jia-Hai .
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (13)
[47]   Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer [J].
Contreras, Jessika A. ;
Lin, Alexander J. ;
Weiner, Ashley ;
Speirs, Christina ;
Samson, Pamela ;
Mullen, Daniel ;
Campian, Jian ;
Bradley, Jeffrey ;
Roach, Michael ;
Robinson, Clifford .
RADIOTHERAPY AND ONCOLOGY, 2018, 128 (03) :498-504
[48]   Diagnostic value of lncRNA HOTAIR as a biomarker for detecting and staging of non-small cell lung cancer [J].
Xin Yao ;
Teng Wang ;
Meng Yang Sun ;
Yang Yuming ;
Duan Guixin ;
Jing Liu .
BIOMARKERS, 2022, 27 (06) :526-533
[49]   Functions of lncRNA DUXAP8 in non-small cell lung cancer [J].
Wu, Cui ;
Song, Wu ;
Wang, Zhongnan ;
Wang, Bingmei .
MOLECULAR BIOLOGY REPORTS, 2022, 49 (03) :2531-2542
[50]   Downregulation of DLL4 predicts poor survival in non-small cell lung cancer patients due to promotion of lymph node metastasis [J].
Liu, Hongzhou ;
Peng, Jie ;
Zhao, Meizhen ;
Ma, Pei ;
Zhong, Jun ;
Li, Shuang ;
Lu, Zhongxin .
ONCOLOGY REPORTS, 2018, 40 (05) :2988-2996